NCT07382141 Early Identification of Cardivascular Damage Induced by Chemotherapy and Antineoplastic Treatments in Pediatric Age
| NCT ID | NCT07382141 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Cardiotoxicity |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2025-03-17 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2025-03-17 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To test whether the implementation of new diagnostic techniques (ultrasonography, speckle tracking, vascular stiffness study, cardiac MRI, and histologic studies) allows in CAYA (Childern, Adolescents, and Young Adults) cancer survivors a more sensitive and earlier identification of cardiovascular damage resulting from antineoplastic therapy that develops either acutely or remotely after completion of antineoplastic therapy.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of oncological pathology and need for antineoplastic treatment Exclusion Criteria: * None
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07382141 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 18 Years, studying Cardiotoxicity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07382141 currently recruiting?
Yes, NCT07382141 is actively recruiting participants. Contact the research team at andrea.donti@aosp.bo.it for enrollment information.
Where is the NCT07382141 trial being conducted?
This trial is being conducted at Bologna, Italy, Bologna, Italy, Bologna, Italy, Bologna, Italy and 1 additional location.
Who is sponsoring the NCT07382141 clinical trial?
NCT07382141 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 400 participants.